Financial conflicts of interest are not being declared by the authors of oncology clinical drug trials published in major medical journals, US figures reveal. One in three authors of clinical trials used as a basis for FDA registration of oncology drugs did not declare financial payments from pharmaceutical sponsors, an analysis published in JAMA shows. ...
Oncologists are failing to declare conflicts of interest
By Michael Woodhead
5 Sep 2018